Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
imatinib ulipristal

increases exposure

Unknown Study
imatinib vemurafenib

increases exposure

Unknown Theoretical
imatinib vincaalkaloids

increases exposure

Unknown Theoretical
imatinib zanubrutinib

increases exposure

Unknown Theoretical
indometacin digoxin

increases concentration

Unknown Study
intravenousceftriaxone intravenouscalciumsalts

increases risk of cardio-respiratoryarrest

Unknown Anecdotal
intravenousmagnesium amlodipine

increases risk of hypotension

Unknown Anecdotal
intravenousmagnesium calciumchannelblockers

increases risk of hypotension

Unknown Anecdotal
intravenousmagnesium felodipine

increases risk of hypotension

Unknown Anecdotal
intravenousmagnesium lacidipine

increases risk of hypotension

Unknown Anecdotal
intravenousmagnesium lercanidipine

increases risk of hypotension

Unknown Anecdotal
intravenousmagnesium neuromuscularblockingdrugs,non-depolarising

increases effects

Unknown Study
intravenousmagnesium nicardipine

increases risk of hypotension

Unknown Anecdotal
intravenousmagnesium nifedipine

increases risk of hypotension

Unknown Anecdotal
intravenousmagnesium nimodipine

increases risk of hypotension

Unknown Anecdotal
intravenousmagnesium suxamethonium

increases effects

Unknown Study
intravenousmagnesium verapamil

increases risk of hypotension

Unknown Anecdotal
irbesartan bulevirtide

affects efficacy

Unknown Theoretical
irinotecan neuromuscularblockingdrugs,non-depolarising

decreases effects

Unknown Theoretical
irinotecan suxamethonium

increases risk of prolongedneuromuscularblockade

Unknown Theoretical
irinotecan suxamethonium

increases risk of prolongede neuromuscularblockade

Unknown Theoretical
iron roxadustat

decreases exposure

Unknown Theoretical
ironchelators ciclosporin

increases risk of immunosuppression

Unknown Theoretical
ironchelators tacrolimus

increases risk of immunosuppression

Unknown Theoretical
isavuconazole alkylatingagents

increases exposure

Unknown Study
isavuconazole atorvastatin

increases exposure

Unknown Study
isavuconazole cyclophosphamide

increases exposure

Unknown Study
isavuconazole fluvastatin

increases exposure

Unknown Theoretical
isavuconazole mycophenolate

increases exposure

Unknown Study
isavuconazole rosuvastatin

increases exposure

Unknown Theoretical
isavuconazole statins

increases exposure

Unknown Study
isavuconazole sulfasalazine

increases exposure

Unknown Theoretical
isavuconazole topotecan

increases exposure

Unknown Theoretical
isometheptene bromocriptine

increases risk of adverseeffects

Unknown Anecdotal
isometheptene dopaminereceptoragonists

increases risk of adverseeffects

Unknown Anecdotal
isoniazid antiepileptics

increases concentration

Unknown Study
isoniazid antiepilepticse

increases concentration

Unknown Study
isoniazid fosphenytoin

increases concentration

Unknown Study
isoniazid levodopa

decreases effects

Unknown Study
isoniazid lomitapide

increases exposure

Unknown Theoretical
isoniazid phenytoin

increases concentration

Unknown Study
itraconazole aliskiren

increases exposure

Unknown Study
itraconazole bosentan

increases exposure

Unknown Theoretical
itraconazole coumarins

increases anticoagulant effect

Unknown Anecdotal
itraconazole endothelinreceptorantagonists

increases exposure

Unknown Theoretical
itraconazole haloperidol

increases concentration

Unknown Study
ivacaftor afatinib

increases exposure

Unknown Study
ivacaftor aliskiren

increases exposure

Unknown Study
ivacaftor antihistamines,non-sedating

increases exposure

Unknown Study
ivacaftor berotralstat

increases exposure

Unknown Study
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.